SCHEMBL1660355

SCHEMBL1660355

O=C(O)c1occ(CF)c1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.36
PTPN1 P18031 1/20 0.36
PTGS2 P35354 1/20 0.33
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
PTGER4 P35408 1/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
CYP2C19 P33261 1/20 0.33
PIN1 Q13526 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28752673 0.85 KMT2A (0.37) KMT2APTPN1PTGS2ALDH1A1LMNA
SCHEMBL27624299 0.77 TSHR (0.43) PTGER4ALDH1A1SMN1; SMN2
SCHEMBL27624306 0.76 PTGER4 (0.46) KMT2APTPN1PTGER4ALDH1A1LMNA
SCHEMBL28290215 0.75 MAOB (0.43) KMT2APTPN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL2097892 0.75 HNF4A (0.43) KMT2APTPN1ALDH1A1LMNASMN1; SMN2
SCHEMBL28752670 0.75 KMT2A (0.45) KMT2AALDH1A1LMNASMN1; SMN2CYP1A2
SCHEMBL8861328 0.74 FABP4 (0.41) PTPN1ALDH1A1LMNAKDM4EHPGD
SCHEMBL27605106 0.70 KMO (0.44) KMT2APTPN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL27624418 0.70 PTPN1 (0.36) PTPN1ALDH1A1LMNAKDM4EHPGD
SCHEMBL3977057 0.69 PTGS1 (0.42) KMT2AALDH1A1LMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed